Tuesday, April 10, 2012

Icahn piles pressure on Amylin with lawsuit

via pharmatimes.com

The lawsuit alleges that Amylin "is a company at a crossroads and that stockholders should be entitled to nominate a new slate of directors committed to pursuing a sale of the company". Mr Icahn has also threatened the firm with another lawsuit if it does not produce copies of its books and records by Wednesday.

Posted via email from Jack's posterous

No comments: